BMJ talk medicine

BMJ talk medicine

By BMJ GroupScience
Download on the App Store

BMJ talk medicine episodes

  • A new biomarker for cognitive dysfunction in SLE?
    Duane Peters from the Lupus Foundation of America interviews Dr Erik Anderson and Dr Meggan Mackay from the Feinstein Institutes for Medical Research in New York in the USA. They discuss their study into imbalances in quinolinic acid and kynurenic acid levels in the brain in SLE patients, and propose that the ratio between these two metabolites could be used as a new biomarker or therapeutic target for cognitive dysfunction.
    Access the paper here: https://lupus.bmj.com/content/8/1/e000559
    16 min
  • Anticoagulant prescribing for atrial fibrillation and risk of incident dementia
    In this episode of the Heart podcast, Digital Media Editor, Dr James Rudd, is joined by Dr Charlotte Warren-Gash and Dr Sharon Cadogan from the London School of Hygiene & Tropical Medicine, London, UK. They discuss their study that demonstrated that prescribing DOACs rather than warfarin was associated with lower incident rates of dementia and mild cognitive impairment.
    If you enjoy the show, please subscribe to the podcast to get episodes automatically downloaded to your phone and computer. Also, please consider leaving us a review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2
    Link to published paper: https://heart.bmj.com/content/107/23/1898.abstract
    17 min
  • ESGO Quality Indicators in Endometrial Cancer with Nicole Concin
    In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Nicole Concin to discuss the article European Society of Gynaecological Oncology quality indicators for the surgical treatment of endometrial carcinoma. Dr. Concin is a gynaecological oncologist, ESGO president, Co-Chair of ENGOT Early Drug Development Network, and Professor at Medical University of Innsbruck, Innsbruck Austria & Kliniken Essen-Mitte, Essen, Germany.
    Related Link: https://ijgc.bmj.com/content/31/12/1508
    46 min
  • Talk Evidence - isolation periods, openness, and environmental impacts
    In the first Talk Evidence of 2022, we'll be asking about the evidence for isolation - now that isolation periods are being reduced, or even stopped in the event of a negative lateral flow test, we'll find out what data that's based on, and if it's appropriate.
    Vaccinations and treatments for covid-19 have been the one major success story of the pandemic, but that doesn't mean we should abandon the principles of openness and transparency when it comes to scrutinising the data - we'll hear what access to the data which underlies regulatory approval could do now.
    Finally, the impacts of climate change were set out in a WHO report in November last year - and recent weather seems to underline their conclusions. We'll discuss new evidence linking the environment and health, and ask what clinicians can do with that.
    Reading list:
    Mitigating isolation: The use of rapid antigen testing to reduce the impact of self-isolation periods
    https://www.medrxiv.org/content/10.1101/2021.12.23.21268326v1.full.pdf
    Covid-19 vaccines and treatments: we must have raw data, now
    https://www.bmj.com/content/376/bmj.o102
    WHO report: Climate change and health
    https://www.who.int/news-room/fact-sheets/detail/climate-change-and-health
    Ambient heat and risks of emergency department visits among adults in the United States: time stratified case crossover study
    https://www.bmj.com/content/375/bmj-2021-065653
    Residential exposure to transportation noise in Denmark and incidence of dementia: national cohort study
    https://www.bmj.com/content/374/bmj.n1954
    Long term exposure to low level air pollution and mortality in eight European cohorts within the ELAPSE project: pooled analysis
    https://www.bmj.com/content/374/bmj.n1904
    36 min
  • To jab or not to jab? Responsible use of orthobiologics and regenerative therapies. EP #495
    In this episode host Dr Brooke Patterson, is joined by Associate Professor Shane Shapiro, to discuss the responsible use of orthobiologics and regenerative therapies in sports medicine. Professor Shapiro provides clinicians with practical considerations and tips for communicating with patients who may be considering the use of orthobiologics.
    Links
    American Medical Society for Sports Medicine Position Statement: Principles for the Responsible Use of Regenerative Medicine in Sports Medicine https://journals.lww.com/cjsportsmed/Fulltext/2021/11000/American_Medical_Society_for_Sports_Medicine.10.aspx
    Editorial - highlights from the American Medical Society for Sports Medicine position statement on responsible use of regenerative medicine and orthobiologics in sports medicine https://bjsm.bmj.com/content/early/2021/10/21/bjsports-2021-104887
    30 min
  • Lyme disease
    Lyme disease is an infectious disease transmitted to humans through the bite of infected ticks.
    Erythema migrans develops at the site of tick bite usually within 1 to 2 weeks and is a pathognomic feature. Constitutional symptoms such as fever, headache, myalgias, fatigue, and arthralgias may occur.
    In this podcast, Janak Koirala, Professor of Medicine and Infectious Diseases, Division of Infectious Diseases, Southern Illinois University School of Medicine, gives us an overview of the condition.
    For more on lyme disease, visit BMJ Best Practice: bestpractice.bmj.com/topics/en-gb/224
    -
    The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.
    14 min
  • Primary Survey - the February 2022 issue in just over 30 minutes!
    Rick Body, Deputy Editor of EMJ, and Sarah Edwards, Social Media Editor of EMJ, talk through the highlights of the February edition of the Emergency Medicine Journal.
    Read the highlights: https://emj.bmj.com/content/39/2/85.
    You can subscribe to the EMJ podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month.
    If you enjoy our podcast, please consider leaving us a review or a comment on the EMJ Podcast iTunes page (https://podcasts.apple.com/us/podcast/emj-podcast/id445358244).
    Thank you for listening!
    34 min
  • Overprescribing, overuse of short-acting beta agonists, inflammatory bowel disease in pregnancy
    In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) provide an overview of the February 2022 issue of DTB. They talk about some of the details from a national report on overprescribing and discuss its implications (https://dtb.bmj.com/content/60/2/18). The editors review a study that highlighted overprescribing of short-acting beta agonists in people with asthma (https://dtb.bmj.com/content/60/2/21). They also discuss an article on prescribing for women of childbearing age who have inflammatory bowel disease and managing medicines during pregnancy (https://dtb.bmj.com/content/60/2/24).
    Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). Thank you for listening.
    22 min